HomeHKPD • NASDAQ
add
Cellyan Biotechnology Co Ltd
Previous close
$0.64
Day range
$0.58 - $0.64
Year range
$0.58 - $2.74
Market cap
6.98M USD
Avg Volume
42.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.57M | -35.65% |
Operating expense | 348.22K | -20.89% |
Net income | 76.87K | -81.45% |
Net profit margin | 2.15 | -71.22% |
Earnings per share | — | — |
EBITDA | 140.86K | -73.41% |
Effective tax rate | 10.52% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.48M | 579.84% |
Total assets | 9.63M | -5.20% |
Total liabilities | 4.49M | -6.65% |
Total equity | 5.14M | — |
Shares outstanding | 11.00M | — |
Price to book | 1.36 | — |
Return on assets | 3.04% | — |
Return on capital | 3.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 76.87K | -81.45% |
Cash from operations | -122.01K | -132.40% |
Cash from investing | -21.25K | 60.04% |
Cash from financing | -134.78K | 70.44% |
Net change in cash | -278.88K | -112.99% |
Free cash flow | 262.17K | -44.55% |
About
Founded
2023
Website
Employees
27
